Navigation Links
NIH clinical study establishes human model of influenza pathogenesis
Date:9/13/2013

WHAT:

A National Institutes of Health (NIH) clinical study of healthy adult volunteers who consented to be infected with the 2009 H1N1 influenza virus under carefully controlled conditions has provided researchers with concrete information about the minimum dose of virus needed to produce mild-to-moderate illness. The study also gives a clearer picture of how much time elapses between a known time of infection, the start of viral shedding (a signal of contagiousness), the development of an immune response, and the onset and duration of influenza symptoms. The data obtained from this study provide a basis for more rapid, cost-effective clinical trials to evaluate new influenza drugs or to determine the efficacy of candidate vaccines for both seasonal and pandemic influenza.

In the study, 46 volunteers were divided into five groups and exposed to influenza virus in escalating doses. The virus, synthesized in the lab under Good Manufacturing Practice conditions, was genetically identical to the virus that caused 2009 H1N1 pandemic influenza. The volunteers all gave informed consent and subsequently were admitted to an isolation unit at the NIH Clinical Center in Bethesda, Md., for a minimum of eight days following virus exposure. The volunteers' health was closely monitored throughout their stay in the clinic and for two months afterward. The researchers sought to determine the minimum dose of virus needed to produce both shedding of live virus in nasal secretions and mild or moderate flu symptoms in 60 percent or more of dosed volunteers. When the scientists administered an influenza virus dose of 107 TCID50 (a measure of the amount of virus required to produce cell death in 50 percent of cultured cells inoculated with virus) to 13 volunteers, 9 (or 69 percent) shed virus and developed symptoms. Lower dosages did not generate responses that met this threshold, thereby establishing the minimum dose of influenza virus needed to produce mild-t
'/>"/>

Contact: Anne A. Oplinger
aoplinger@niaid.nih.gov
301-402-1663
NIH/National Institute of Allergy and Infectious Diseases
Source:Eurekalert

Page: 1 2

Related medicine news :

1. First targeted nanomedicine to enter human clinical studies
2. Clinical insight improves treatment with new lung cancer drug
3. Clinical news alert from the American Academy of Orthopaedic Surgeons
4. NYU Langone experts present research, clinical advances at neurosurgeons meeting
5. Kroenke honored for outstanding contributions in clinical research training
6. Awards celebrate clinical research that can improve health and alleviate suffering
7. Association for Psychological Science, SAGE launch Clinical Psychological Science
8. URMC clinical trial tests new regimen for hypertension
9. Analysis Finds Clinical Trials Often Small, of Poor Quality
10. Automated insulin dosage titration system demonstrates positive clinical study results
11. Clinical news alert: Journal of the American Academy of Orthopaedic Surgeons May highlights
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/28/2015)... Andrew Hawley of Vintage Rock Posters Inc., ... posters. The Who and the Doors played together at the ... According to Hawley, “The Who toured the United States heavily ... campuses. Perhaps the most famous Who poster was a poster ... Doors on August 2, 1968 at the Singer Bowl in ...
(Date:3/28/2015)... Healthpointe’s otolaryngologists, medical practitioners who attend ... disorders, are now offering a wide variety of treatments ... characterized by the presence of phantom sounds or ringing ... is a prevalent symptom that can arise due to ... tinnitus can impede a person’s quality of life. , ...
(Date:3/28/2015)... 28, 2015 ARDX will sponsor the 7th ... -3pm at the Chesapeake Conference Center in Chesapeake, Virginia. ... empowering event for women in the Hampton Roads region. ... of Women’s Lives. Women grow stronger through sharing their ... This year the WWC™ theme is T-talk where we ...
(Date:3/28/2015)... Ontario (PRWEB) March 28, 2015 LTW ... have agreed to collaborate for the purpose of addressing ... technology venture will pursue its own opportunities to grow ... are part of LTW Cyber. , Ventures in LTW ... firmware, and complemented by offerings identifying vulnerabilities and analyzing ...
(Date:3/27/2015)... 2015 In her mid-forties and with a ... working, Monica K. arrived at JET Uniform & Supply ... defensive and scared. The owners and staff at JET, which ... (EPSS) to offer jobs to challenged residents like Monica, were ... willingness to begin with the end in mind,” says Stephen ...
Breaking Medicine News(10 mins):Health News:Avid Collector from Vintage Rock Posters, Inc. Announces His Search For Original 1960's Who Psychedelic Concert Posters. 2Health News:Healthpointe now Offering Tinnitus Treatments in Clinics throughout Southern California 2Health News:Canadian Cybersecurity Ventures Globalize as a Collective 2Health News:Canadian Cybersecurity Ventures Globalize as a Collective 3Health News:Red Deer Uniforms Shop Celebrates 3rd Year Sewing Hope for the Challenged 2Health News:Red Deer Uniforms Shop Celebrates 3rd Year Sewing Hope for the Challenged 3
... -- A little-known morphinelike drug is potentially more ... constipation than standard morphine, a study led by ... The drug, morphine-6-0-sulfate, has a similar chemical ... and colleagues reported that a study they performed ...
... (January 4, 2011) -- Cumbersome glaucoma tests requiring a ... to a home test developed by an engineer at ... involving a system of micro-force sensors, specially designed microchips, ... at the UA College of Engineering. The easy-to-use probe ...
... WA, have found that clinical decision support systems can ... (CT) and magnetic resonance imaging (MRI) scans, according to ... Journal of the American College of Radiology ( ... point-of-order decision aids, usually through computer order entry systems, ...
... frequently use portable media (CDs, DVDs) to review patient ... resonance imaging (MRI) and computed tomography (CT) scans, but ... media exist, according to a study in the January ... of Radiology ( www.jacr.org ). "Because of ...
... SEVERE ASTHMA ... effective an add-on treatment to corticosteroids for moderate to severe ... Chile performed a meta-analysis on eight trials where 1,883 patients ... of the steroid reduction phase, patients taking omalizumab were more ...
... News) -- Post-traumatic stress disorder may have long-term effects ... -- while those who suffer from concussions and mild ... the long haul, a new study suggests. ... Enduring Freedom and Operation Iraqi Freedom since 2001," according ...
Cached Medicine News:Health News:Experimental drug more potent, longer lasting than morphine 2Health News:New glaucoma test allows earlier, more accurate detection 2Health News:Study finds problems with reviewing medical images from portable media 2Health News:News briefs from the January issue of Chest 2Health News:Soldiers' PTSD Tied to Lasting Psychosocial Effects 2
(Date:3/27/2015)... March 27, 2015 As of February, ... incontinence devices for women. "Shipping thousands ... gratifying part is the hundreds of letters, emails ... lives have been positively impacted by our technology," ... InControl recently released Apex, an over-the-counter ...
(Date:3/27/2015)... 2015  Johnson & Johnson (NYSE: JNJ ) will ... Time) on Thursday, April 23, 2015, from the State Theatre ... Investors and other interested parties may access the live audio ... www.jnj.com and clicking on the webcast icon. ... made available a few hours after the live meeting concludes. ...
(Date:3/27/2015)... , March 27, 2015  WebMD Health ... source of health information, today announced an ... National Action Plan for Combating Antibiotic-Resistant ... emphasized the urgency and importance of addressing ... and global health.    The WebMD ...
Breaking Medicine Technology:InControl Medical Surpasses 40,000 Shipments Of Incontinence Devices For Women 2Exclusive: WebMD Interviews President Obama About Plan for Combating Antibiotic Resistance 2Exclusive: WebMD Interviews President Obama About Plan for Combating Antibiotic Resistance 3
... Inc. (NASDAQ: STXS ) today announced that ... to be held on December 13-14, 2011 in New ... Stereotaxis, is scheduled to present an overview of the ... ET.  A live webcast and subsequent ...
... YORK, Dec. 2, 2011 Levi & Korsinsky is ... Abbott Laboratories, Inc. ("Abbott" or the "Company") (NYSE: ... regarding the marketing and sale of the anti-seizure medication ... http://zlk.9nl.com/abbott-laboratories-abt . From as early as 1998, ...
Cached Medicine Technology:Stereotaxis to Present at the Oppenheimer Healthcare Conference on December 13, 2011 2Stereotaxis to Present at the Oppenheimer Healthcare Conference on December 13, 2011 3The Law Firm of Levi & Korsinsky Launches an Investigation Into Possible Breaches of Fiduciary Duties and Unjust Enrichment by the Board of Directors of Abbott Laboratories, Inc. 2
Lorgnette pinhole occluder...
9 inch double ended with one end black and the other end with 49 holes...
6 inch hand held occlcuder with 49 holes...
Double Ended Occluders...
Medicine Products: